View Document Preview and Link Document Date: 2013-09-27 09:05:18 Open Document File Size: 1,76 MB Share Result on Facebook
Company Amazon / Agency for Healthcare Research / / Continent Asia / / Country United States / / Currency USD / / / IndustryTerm inactive carrier / medical and public health services / HBV therapies / hepatitis therapy / HBV therapy / / MedicalCondition acute hepatitis B / AM Introduction Hepatitis B / HIV / HBV / liver failure / cirrhosis / Hepatitis B / Hepatitis B CS.indd / hepatitis / liver disease / both acute and chronic HBV infection / HBV genotype / acute liver failure / HBV infection / disease / acute HBV infection / hepatocellular carcinoma / Infection Hepatitis B / chronic HBV infection / progressive disease / C infection / HCV / diseases / advanced fibrosis / infectious diseases / latent HBV infection / infection / acute hepatitis B. The / Symptomatic infection / chronic infection / chronic hepatitis B / fibrosis / / MedicalTreatment immunization / vaccination / chemotherapy / Antiviral therapy / immunosuppression / / NaturalFeature Pacific Islands / / Organization National Institute of Health / U.S. government / NIH Consensus Development Program Information Center / NATIONAL INSTITUTES OF HEALTH office / Minnesota Evidence-based Practice Center / Agency for Healthcare Research and Quality / / Person Johnson JR / B. Ann Intern Med / Ann Intern / / / Position public representative / Governor / Director / Director 52 / 665 Hepatitis / representative / / Product tenofovir disoproxil fumarate / lamivudine / / ProvinceOrState Maryland / / Region sub-Saharan Africa / Eastern Europe / / Technology transplantation / chemotherapy / genotype / / URL www.ahrq.gov/clinic/tp/hepbtp.htm / http / SocialTag 
NIH Consensus Development Conference Statement on Management of Hepatitis B NIH Consensus and State-of-the-Science Statements Volume 25, Number 2